UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics

PloS one, 2022-02, Vol.17 (2), p.e0264637-e0264637

2022

Link zum Volltext

Verfügbarkeit prüfen

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer

Clinical cancer research, 2017-08, Vol.23 (16), p.4780-4792

2017

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer: Current Molecular Therapeutic Targets and New Players

Anti-cancer agents in medicinal chemistry, 2017-02, Vol.17 (2), p.152

Nagini, Siddavaram

2017

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

The New England journal of medicine, 2017-06, Vol.376 (22), p.2147-2159

2017

Link zum Volltext

Verfügbarkeit prüfen

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

The New England journal of medicine, 2017-11, Vol.377 (19), p.1836-1846

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

The lancet oncology, 2018-01, Vol.19 (1), p.27-39

2018

Link zum Volltext

Verfügbarkeit prüfen

Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

Annals of oncology, 2014-08, Vol.25 (8), p.1536-1543

2014

Link zum Volltext

Verfügbarkeit prüfen

Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer

JNCI : Journal of the National Cancer Institute, 2016-03, Vol.108 (3), p.djv330

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical implications of the intrinsic molecular subtypes of breast cancer

Breast (Edinburgh), 2015-11, Vol.24, p.S26-S35

2015

Link zum Volltext

Verfügbarkeit prüfen

Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial

The lancet oncology, 2022-12, Vol.23 (12), p.1517-1524

2022

Link zum Volltext

Verfügbarkeit prüfen

When and How Do I Use Neoadjuvant Chemotherapy for Breast Cancer?

Current treatment options in oncology, 2014-03, Vol.15 (1), p.86-98

2014

Link zum Volltext

Verfügbarkeit prüfen

Molecular and cellular mechanisms underlying brain metastasis of breast cancer

Cancer and metastasis reviews, 2020-09, Vol.39 (3), p.711-720

2020

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant

Journal of clinical oncology, 2020-02, Vol.38 (5), p.388-394

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeting the NFκB signaling pathways for breast cancer prevention and therapy

Current medicinal chemistry, 2015-01, Vol.22 (2), p.264

2015

Link zum Volltext

Verfügbarkeit prüfen

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

The Lancet (British edition), 2011-08, Vol.378 (9793), p.771-784

2011

Link zum Volltext

Verfügbarkeit prüfen

Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer

Annals of oncology, 2020-03, Vol.31 (3), p.377-386

2020

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

The Lancet (British edition), 2015-10, Vol.386 (10001), p.1353-1361

2015

Link zum Volltext

Verfügbarkeit prüfen

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

Cancer cell, 2018-09, Vol.34 (3), p.427-438.e6

2018

Link zum Volltext

Verfügbarkeit prüfen

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer

The New England journal of medicine, 2020-02, Vol.382 (6), p.514-524

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients

Annals of surgical oncology, 2016-05, Vol.23 (5), p.1515-1521

2016

Link zum Volltext

Verfügbarkeit prüfen

Role of epidermal growth factor receptor in breast cancer

Breast cancer research and treatment, 2012-11, Vol.136 (2), p.331-345

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 82.464

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74.963)
Mit Volltextzugriff
(65.218)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(76.376)
Japanisch
(11.085)
Deutsch
(1.223)
Französisch
(1.093)
Chinesisch
(617)
Russisch
(529)
Italienisch
(389)
Spanisch
(297)
Portugiesisch
(195)
Polnisch
(134)
Niederländisch
(100)
Ungarisch
(98)
Dänisch
(81)
Norwegisch
(59)
Tschechisch
(45)
Schwedisch
(44)
Hebräisch
(33)
Finnisch
(30)
Bulgarisch
(19)
Croatian
(19)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(80.351)
Female
(70.286)
Science & Technology
(66.417)
Life Sciences & Biomedicine
(62.161)
Breast Neoplasms - Drug Therapy
(60.020)
Breast Cancer
(38.874)
Oncology
(38.399)
Middle Aged
(27.174)
Breast Neoplasms - Pathology
(26.651)
Adult
(20.635)
Aged
(19.876)
Tumors
(16.833)
Biological And Medical Sciences
(16.520)
Chemotherapy
(16.163)
Medical Sciences
(16.105)
Animals
(14.802)
Cell Line, Tumor
(14.178)
Breast Neoplasms - Metabolism
(12.968)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12.564)
Cancer Therapies
(12.015)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(38.660)
Ingenta
(36.020)
Journals@Ovid Ovid Full Text 学内アクセス
(31.063)
IngentaConnect Journals
(19.747)
Single Journals
(15.889)
Elsevier ScienceDirect Journals Complete
(14.021)
SpringerNature Journals
(13.221)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(9.932)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(8.973)
Wiley Online Library
(7.642)
Wiley Online Library Full Collection 2018
(5.139)
North East Research Libraries Nature Academic Titles
(3.696)
Nexis Uni
(3.069)
Taylor & Francis Current Content Access
(2.812)
Taylor & Francis Journals Complete
(2.595)
Oxford University Press Journals Current
(2.105)
SpringerLink Series
(1.747)
Oxford Journals 2020 Medicine
(1.639)
SAGE Complete
(1.522)
JSTOR
(891)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Breast Cancer Research And Treatment
(3.367)
Journal Of Clinical Oncology
(2.294)
Plos One
(1.765)
Annals Of Oncology
(1.513)
Gan To Kagaku Ryoho
(1.476)
Cancer
(1.298)
Clinical Cancer Research
(1.232)
British Journal Of Cancer
(1.149)
Cancer Research
(1.133)
European Journal Of Cancer
(1.077)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells

Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer

Breast Cancer: Current Molecular Therapeutic Targets and New Players

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer

Clinical implications of the intrinsic molecular subtypes of breast cancer

Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial

When and How Do I Use Neoadjuvant Chemotherapy for Breast Cancer?

CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

Molecular and cellular mechanisms underlying brain metastasis of breast cancer

Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant

Targeting the NFκB signaling pathways for breast cancer prevention and therapy

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer

Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

Role of epidermal growth factor receptor in breast cancer

Suchergebnisse filtern